Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-1403-2025

ZIMMER ORTHOPEDICS MANFACTURING LIMITED-GALWAY recalls Comprehensive Shoulder Stem

ZIMMER ORTHOPEDICS MANFACTURING LIMITED-GALWAYOranmore, IrelandReported Mar 26, 2025 · 1 year ago
Legal News Analyst ·

Reason for recall

Five complaints received where surgeon was unable to remove and/or connect the inserter with the stem during surgery due to excess material remaining within the taper. Issue may lead to clinically significant extension of surgery to find a replacement.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Comprehensive Shoulder Stem, Comprehensive Micro Stem, Comprehensive Mini Stem; uncemented shoulder prosthesis, Model Nos. 113605, 113606, 113607, 113627

Lot / code information

Part / Item #
113605
UDI
00887868267550 Lots 66173214, 66173215
Part / Item #
113606
UDI
00887868267567 Lots 66173216, 66173218, 66173219
Part / Item #
113607
UDI
00887868267574 Lots 66173220, 66173221
Part / Item #
113627
UDI
00887868267741 Lots 65901697, 65909480, 65915809

What the firm is doing

On March 3, 2025, the firm notified affected customers via Urgent Medical Device Recall letters. Customers were informed of the excess metal on the inner taper of the stem due to a chipped manufacturing tool. Customers were asked to notify all affected persons and assist their Zimmer Biomet sales representative in quarantining all affected product on hand. The products will be removed from your facility.

DistributionShow details

US distribution nationwide. International distribution to Dominican Republic, Canada, India, Australia, Japan, EMEA, Korea, Taiwan, and Hong Kong.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls